10-K
XBRL
ANNUAL REPORT
- Company
- Lexaria Bioscience Corp.
- Filed
- January 30, 2012
- Period of Report
- October 31, 2011
- Accession Number
- 0001062993-12-000301
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →